Raltegravir

Details

Files
Generic Name:
Raltegravir
Project Status:
Complete
Therapeutic Area:
HIV (treatment naïve)
Manufacturer:
Merck Frosst Canada Ltd.
Brand Name:
Isentress
Project Line:
Reimbursement Review
Project Number:
SR0191-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
HIV (treatment naïve)
Recommendation Type:
Do not list
Final Recommendation: